| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |